.
.
august 2, 2017.
.

.
why novartis� landmark cancer drug approval is great news for bluebird.
"there is an issue that needs to be addressed in terms of the narrative the health trust tried to present and mislead the inquest and cover up what actually happened..
.
advertisement
.
the obvious reason: their big-spending pharmaceutical advertisers would drop them like hot potatoes.. nightlife: filthy mcnastys, belfast - friday 11 & saturday 12 may 2018 [photos]